Journal article icon

Journal article

Myocardial fibrosis and tissue alterations predict cardiovascular outcomes in chronic kidney disease—a prospective virtual twin study design using large-scale population database

Abstract:
Background: Myocardial fibrosis is a key feature of chronic kidney disease (CKD) and may contribute to its disproportionate cardiovascular (CV) burden. Cardiovascular magnetic resonance (CMR) T1-mapping quantifies diffuse fibrosis non-invasively, but its prognostic value in CKD remains uncertain Aims: To investigate associations between native myocardial T1, mortality and incident CV outcomes, in CKD using a virtual twin-matching framework within the UK Biobank imaging cohort. Methods: We conducted a 1:1 virtual twin-matched case-cohort study of CKD cases and phenotypically matched non-CKD controls based on demographics, comorbidities, socioeconomic status, and cardiovascular risk factors. Paired analyses compared myocardial T1 between groups, and stratified Cox models estimated the effect of a 1-SD T1 increase on incident outcomes over a median follow-up of 4.9 years. Results: Among 193 matched pairs (median age 68 years; 57.5% women), CKD participants had trend-level higher myocardial T1 values than controls (p = 0.063), with greater differences among those experiencing adverse outcomes. Over follow-up, CKD participants had higher cumulative incidences of all-cause mortality (11.3 vs. 3.8 events/1,000 person-years; p = 0.049) and heart failure (12.7 vs. 3.9 events/1,000 person-years; p = 0.021). In CKD, each 1-SD increase in T1 was associated with higher risks of cardiovascular death (HR: 3.86; 95% CI: 1.62, 9.18), heart failure (HR: 2.00; 95% CI: 1.27, 3.15), and atrial fibrillation (HR: 2.04; 95% CI: 1.01, 4.12), but not all-cause mortality or myocardial infarction. No significant associations were observed in matched non-CKD controls. Conclusions: Elevated native myocardial T1 was independently associated with CV death, heart failure, and atrial fibrillation in CKD. Virtual twin-matching framework improved comparability and internal validity in matched pairs supporting the precision-matched cohort designs for mechanistic inference and risk stratification in multimorbid populations.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3389/fcvm.2026.1726445

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Radcliffe Department of Medicine
Sub department:
RDM-Strategic
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Radcliffe Department of Medicine
Sub department:
RDM-Strategic
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Radcliffe Department of Medicine
Sub department:
RDM-Strategic
Role:
Author


Publisher:
Frontiers Media
Journal:
Frontiers in Cardiovascular Medicine More from this journal
Volume:
13
Article number:
1726445
Publication date:
2026-05-11
Acceptance date:
2026-04-08
DOI:
EISSN:
2297-055X
ISSN:
2297-055X


Language:
English
Keywords:
Source identifiers:
4076758
Deposit date:
2026-05-25
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP